Nuzenio

Tarsus Reports Second

Tarsus Reports Second news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 17 latest news signals 14 publisher sources 100/100 entity strength

Latest news

Why Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.stsimplywall.st · Sun, 09 Aug 2026 08:50:33 GMT Tarsus Pharmaceuticals Q2 Earnings Call Highlights - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 17:04:07 GMT Midday Stock Roundup: Karman Market Cap Surges on Earnings - Orange County Business JournalOrange County Business Journal · Fri, 07 Aug 2026 16:30:20 GMT Tarsus to Acquire Alkeus in $450 Million Deal, Reports Strong Quarter and Half - VisionMonday.comVisionMonday.com · Fri, 07 Aug 2026 04:24:00 GMT Tarsus Pharmaceuticals Reports Loss for Q2 2026, Misses Estimates - AlphaStreetAlphaStreet · Thu, 06 Aug 2026 19:42:28 GMT Tarsus builds retina franchise in USD 800 million Alkeus deal - AllSciAllSci · Thu, 06 Aug 2026 16:30:44 GMT Tarsus to expand eye disease pipeline with up to $800 million Alkeus acquisition - ReutersReuters · Thu, 06 Aug 2026 13:55:38 GMT Earnings call transcript: Tarsus beats revenue in Q2 2026, but EPS miss weighs on shares - Investing.comInvesting.com · Thu, 06 Aug 2026 13:00:00 GMT

Timeline

Sun, 09 Aug 2026 08:50:33 GMTWhy Tarsus Pharmaceuticals (TARS) Is Up 9.7% After Raising XDEMVY 2026 Sales Guidance And Acquiring Alkeus - simplywall.st

Fri, 07 Aug 2026 17:04:07 GMTTarsus Pharmaceuticals Q2 Earnings Call Highlights - Yahoo Finance

Fri, 07 Aug 2026 16:30:20 GMTMidday Stock Roundup: Karman Market Cap Surges on Earnings - Orange County Business Journal

Fri, 07 Aug 2026 04:24:00 GMTTarsus to Acquire Alkeus in $450 Million Deal, Reports Strong Quarter and Half - VisionMonday.com

Thu, 06 Aug 2026 19:42:28 GMTTarsus Pharmaceuticals Reports Loss for Q2 2026, Misses Estimates - AlphaStreet

Thu, 06 Aug 2026 16:30:44 GMTTarsus builds retina franchise in USD 800 million Alkeus deal - AllSci

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Tarsus13 live mentions Alkeus8 live mentions TARS6 live mentions Tarsus Pharmaceuticals6 live mentions Earnings5 live mentions Stargardt4 live mentions Financial Results4 live mentions Pharmaceuticals3 live mentions Investing3 live mentions Why Tarsus Pharmaceuticals2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tarsus Reports Second.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

14 distinct publisher/source names are currently connected to this entity page.